Institutional investors purchased a net $233.7 thousand shares of SCLN during the quarter ended March 2017, and now own 71.66% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 614.7 Thousand shares of SciClone Pharmaceuticals ...
STONEPINE CAPITAL MANAGEMENT LLC Bought 414.1 Thousand shares of SciClone Pharmaceuticals ...